Le Lézard
Classified in: Health
Subjects: PER, DIS

Tena L. McNamara, CCC-A/SLP, Becomes 2024 President of the American Speech-Language-Hearing Association


Tena L. McNamara, CCC-A/SLP, took office this month as the 2024 president of the American Speech-Language-Hearing Association.

ROCKVILLE, Md., Jan. 2, 2024 /PRNewswire-PRWeb/ -- Tena L. McNamara, CCC-A/SLP, took office this month as the 2024 president of the American Speech-Language-Hearing Association (ASHA).

"I look forward to working with the ASHA board, staff, and members to expand the legacy of excellence and innovation that ASHA has established over the years."

McNamara is an audiologist and speech-language pathologist who specializes in aural habilitation/rehabilitation therapy, audiological assessment, literacy, and (central) auditory processing diagnostics and intervention. Previously, she served ASHA as a member of various councils and ad hoc committees, reviewer for scholarships and awards, and co-chair for the 2021 ASHA Convention in Washington, D.C. She is also a Fellow of both ASHA and the Illinois Speech-Language-Hearing Association.

As ASHA's president, McNamara will lead the Association's efforts to advance the professions of audiology and speech-language pathology, advocate for the rights and interests of people with communication disorders, and promote the highest standards of ethical and professional practice.

"I am honored and humbled to serve as the president of ASHA," McNamara said. "I look forward to working with the ASHA board, staff, and members to expand the legacy of excellence and innovation that ASHA has established over the years. I am also excited to embrace the opportunities and challenges that lie ahead as we navigate the changing landscape of health care, education, and technology in the 21st century."

McNamara's work experience includes employment in an academic setting for 25 years and practicing as an educational audiologist for 27 years. Currently, she works as an audiologist for a private practice pediatric center and oversees the development of a cultural and educational resource center for children and adults who are deaf or hard of hearing and their families.

About the American Speech-Language-Hearing Association (ASHA)

ASHA is the national professional, scientific, and credentialing association for 228,000 members and affiliates who are audiologists; speech-language pathologists; speech, language, and hearing scientists; audiology and speech-language pathology assistants; and students. Audiologists specialize in preventing and assessing hearing and balance disorders as well as providing audiologic treatment, including hearing aids. Speech-language pathologists (SLPs) identify, assess, and treat speech, language, and swallowing disorders. http://www.asha.org

View all ASHA press releases at https://www.asha.org/about/press-room/.

Media Contact

Jeremi Jones, American Speech-Language-Hearing Association, 301-296-8729, [email protected], asha.org

SOURCE American Speech-Language-Hearing Association


These press releases may also interest you

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: